These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8673026)

  • 41. [French validation of the Revised Paranormal Belief Scale].
    Bouvet R; Djeriouat H; Goutaudier N; Py J; Chabrol H
    Encephale; 2014 Sep; 40(4):308-14. PubMed ID: 24836860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Schizotypal features in obsessive-compulsive disorder.
    Stanley MA; Turner SM; Borden JW
    Compr Psychiatry; 1990; 31(6):511-8. PubMed ID: 2265535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients.
    Siever LJ; Silverman JM; Horvath TB; Klar H; Coccaro E; Keefe RS; Pinkham L; Rinaldi P; Mohs RC; Davis KL
    Arch Gen Psychiatry; 1990 Jul; 47(7):634-40. PubMed ID: 2360857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders.
    Fenton WS; McGlashan TH; Victor BJ; Blyler CR
    Am J Psychiatry; 1997 Feb; 154(2):199-204. PubMed ID: 9016268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Schizotypal disorder.
    Battaglia M; Bellodi L
    Hosp Community Psychiatry; 1992 Jan; 43(1):82-3. PubMed ID: 1544660
    [No Abstract]   [Full Text] [Related]  

  • 46. Personality traits in schizophrenia and related personality disorders.
    Camisa KM; Bockbrader MA; Lysaker P; Rae LL; Brenner CA; O'Donnell BF
    Psychiatry Res; 2005 Jan; 133(1):23-33. PubMed ID: 15698674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Schizotypal dimensions: continuity between schizophrenia and bipolar disorders.
    Schürhoff F; Laguerre A; Szöke A; Méary A; Leboyer M
    Schizophr Res; 2005 Dec; 80(2-3):235-42. PubMed ID: 16169190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Schizotypal traits in adolescents: links to family history of psychosis and psychological distress.
    Cella M; Serra M; Lai A; Mason OJ; Sisti D; Rocchi MB; Preti A; Petretto DR
    Eur Psychiatry; 2013 May; 28(4):247-53. PubMed ID: 22964111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dissociative experience in hypothetically psychosis-prone college students.
    Pope CA; Kwapil TR
    J Nerv Ment Dis; 2000 Aug; 188(8):530-6. PubMed ID: 10972573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Additional support for the cognitive model of schizophrenia: evidence of elevated defeatist beliefs in schizotypy.
    Luther L; Salyers MP; Firmin RL; Marggraf MP; Davis B; Minor KS
    Compr Psychiatry; 2016 Jul; 68():40-7. PubMed ID: 27234181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is early adulthood a critical developmental stage for psychosis proneness? A survey of delusional ideation in normal subjects.
    Verdoux H; van Os J; Maurice-Tison S; Gay B; Salamon R; Bourgeois M
    Schizophr Res; 1998 Feb; 29(3):247-54. PubMed ID: 9516665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The inter-rater and test-retest reliabilities of prodromal symptoms in first-episode psychosis.
    Jackson HJ; McGorry PD; Dakis J; Harrigan S; Henry L; Mihalopoulos C
    Aust N Z J Psychiatry; 1996 Aug; 30(4):498-504. PubMed ID: 8887700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A latent profile analysis of schizotypal dimensions: Associations with psychopathology and personality.
    Fonseca-Pedrero E; Ortuño-Sierra J; de Álbeniz AP; Muñiz J; Cohen AS
    Psychiatry Res; 2017 Jul; 253():110-115. PubMed ID: 28364588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cannabis use correlates with schizotypy in healthy people.
    Williams JH; Wellman NA; Rawlins JN
    Addiction; 1996 Jun; 91(6):869-77. PubMed ID: 8696249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic expression of schizotypal traits in an adolescent population.
    Fonseca-Pedrero E; Lemos-Giráldez S; Paino M; Sierra-Baigrie S; Muñiz J
    J Pers Disord; 2012 Aug; 26(4):539-50. PubMed ID: 22867505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychometric properties and concurrent validity of the schizotypal ambivalence scale.
    Kwapil TR; Mann MC; Raulin ML
    J Nerv Ment Dis; 2002 May; 190(5):290-5. PubMed ID: 12011608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Inventory of Psychotic-Like Anomalous Self-Experiences (IPASE): Development and validation.
    Cicero DC; Neis AM; Klaunig MJ; Trask CL
    Psychol Assess; 2017 Jan; 29(1):13-25. PubMed ID: 27054620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early maladaptive schemas in patients with schizophrenia and non-patients with high and low schizotypal traits and their differences based on depression severity.
    Khosravani V; Mohammadzadeh A; Sheidaei Oskouyi L
    Compr Psychiatry; 2019 Jan; 88():1-8. PubMed ID: 30458342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Confirmatory factor analysis of the three-factor structure of the schizotypal personality questionnaire and Chapman schizotypy scales.
    Wuthrich VM; Bates TC
    J Pers Assess; 2006 Dec; 87(3):292-304. PubMed ID: 17134337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Social competence and adolescent psychosis.
    Amminger GP; Mutschlechner R; Resch F
    Br J Psychiatry; 1994 Aug; 165(2):273. PubMed ID: 7802850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.